Furthermore, these fatty acids decrease the release of glucose into the blood; reduce the incidence of lipid and leptin resistance, serum cholesterol, and LDL levels; and elevate the YY peptide, which plays a vital role in appetite—making modified starch a good option for patients with obesity or diabetes. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.